Blog

Bellerophon shares plummet after heart drug fails in study

Bellerophon Therapeutics Inc’s shares plummeted more than 60 percent on Monday after the company said an injectable heart drug it is developing under license failed in a study. The drug, bioabsorbable cardiac matrix, was licensed from BioLineRx Ltd in 2009 after animal studies showed that it acted as a “scaffold” to support the heart wall and was likely to prevent further structural damage. When BCM is administered after a heart

UK checking two suspected MERS cases in northern England

Two suspected cases of the Middle Eastern Respiratory Virus Syndrome (MERS) have forced a hospital in northern England to shut its emergency department, health officials said on Monday. Two patients at Manchester Royal Infirmary were placed in isolation, but there was no significant risk to others at the hospital or to the general public, Central Manchester University Hospitals Trust said. “Manchester Royal Infirmary Accident and Emergency Department will be closed

NHTSA Fines Fiat-Chrysler up to $105 Million, Jeep Owners Get $100 Gift Cards

– The federal government has fined Fiat-Chrysler $70 million for untimely responses to a series of recalls and forced the automaker to buy back a half-million vehicles, among many strict provisos announced Sunday night by the National Highway Traffic Safety Administration. – – In a consent order signed Friday by CEO Sergio Marchionne, FCA could face up to $105 million in civil penalties—the most ever levied against an automaker—except federal